(EXFY) Expensify - Overview
Stock: Expense Management, Corporate Cards, Bill Pay, Invoicing, Travel Booking
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 76.2% |
| Relative Tail Risk | -14.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.44 |
| Alpha | -82.55 |
| Character TTM | |
|---|---|
| Beta | 1.263 |
| Beta Downside | 1.537 |
| Drawdowns 3y | |
|---|---|
| Max DD | 87.20% |
| CAGR/Max DD | -0.55 |
Description: EXFY Expensify January 01, 2026
Expensify Inc. (NASDAQ: EXFY) operates a cloud-based expense-management platform that automates corporate card administration, bill payment, invoice creation, payment collection, and travel booking, while also supporting individual expense tracking. The service is sold to a spectrum of customers-from solo professionals to large enterprises-across the United States and international markets, and the company has been headquartered in Portland, Oregon since its 2008 founding.
In its most recent fiscal year (2023), Expensify reported revenue of roughly $115 million, reflecting a year-over-year increase of about 15 % driven largely by higher adoption of its corporate card integration and a surge in subscription renewals amid continued remote-work trends. The SaaS expense-management sector is expanding at a compound annual growth rate (CAGR) of ~12 % globally, propelled by enterprises seeking tighter spend controls and automated compliance, which serves as a tailwind for Expansify’s addressable market. A key operational metric, net dollar retention, hovered near 110 % in Q4 2023, indicating that existing customers are expanding usage faster than churn erodes the base.
For analysts looking to deepen their valuation framework, a quick look at ValueRay’s proprietary cash-flow sensitivity models can surface hidden upside or downside scenarios that aren’t obvious from headline numbers alone.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -15.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 8.34 > 1.0 |
| NWC/Revenue: 75.19% < 20% (prev 65.63%; Δ 9.56% < -1%) |
| CFO/TA 0.14 > 3% & CFO 25.3m > Net Income -15.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (92.6m) vs 12m ago 4.97% < -2% |
| Gross Margin: 50.78% > 18% (prev 0.54%; Δ 5023 % > 0.5%) |
| Asset Turnover: 79.27% > 50% (prev 77.98%; Δ 1.29% > 0%) |
| Interest Coverage Ratio: -25.09 > 6 (EBITDA TTM -7.28m / Interest Expense TTM 539.0k) |
Altman Z'' -2.97
| A: 0.58 (Total Current Assets 152.6m - Total Current Liabilities 44.4m) / Total Assets 186.8m |
| B: -0.88 (Retained Earnings -165.1m / Total Assets 186.8m) |
| C: -0.07 (EBIT TTM -13.5m / Avg Total Assets 181.5m) |
| D: -3.23 (Book Value of Equity -165.1m / Total Liabilities 51.2m) |
| Altman-Z'' Score: -2.97 = D |
Beneish M -3.32
| DSRI: 0.92 (Receivables 12.3m/12.8m, Revenue 143.9m/137.4m) |
| GMI: 1.07 (GM 50.78% / 54.45%) |
| AQI: 0.83 (AQ_t 0.09 / AQ_t-1 0.10) |
| SGI: 1.05 (Revenue 143.9m / 137.4m) |
| TATA: -0.22 (NI -15.6m - CFO 25.3m) / TA 186.8m) |
| Beneish M-Score: -3.32 (Cap -4..+1) = AA |
What is the price of EXFY shares?
Over the past week, the price has changed by -4.83%, over one month by -2.82%, over three months by +1.47% and over the past year by -64.25%.
Is EXFY a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EXFY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.8 | 105.1% |
| Analysts Target Price | 2.8 | 105.1% |
| ValueRay Target Price | 0.8 | -39.9% |
EXFY Fundamental Data Overview February 03, 2026
P/B = 0.9944
Revenue TTM = 143.9m USD
EBIT TTM = -13.5m USD
EBITDA TTM = -7.28m USD
Long Term Debt = 5.93m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 720.0k USD (from shortTermDebt, last quarter)
Debt = 5.93m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -55.5m USD (from netDebt column, last quarter)
Enterprise Value = 79.4m USD (134.9m + Debt 5.93m - CCE 61.5m)
Interest Coverage Ratio = -25.09 (Ebit TTM -13.5m / Interest Expense TTM 539.0k)
EV/FCF = 3.49x (Enterprise Value 79.4m / FCF TTM 22.8m)
FCF Yield = 28.67% (FCF TTM 22.8m / Enterprise Value 79.4m)
FCF Margin = 15.82% (FCF TTM 22.8m / Revenue TTM 143.9m)
Net Margin = -10.83% (Net Income TTM -15.6m / Revenue TTM 143.9m)
Gross Margin = 50.78% ((Revenue TTM 143.9m - Cost of Revenue TTM 70.8m) / Revenue TTM)
Gross Margin QoQ = 49.62% (prev 51.94%)
Tobins Q-Ratio = 0.42 (Enterprise Value 79.4m / Total Assets 186.8m)
Interest Expense / Debt = 9.09% (Interest Expense 539.0k / Debt 5.93m)
Taxrate = 21.0% (US default 21%)
NOPAT = -10.7m (EBIT -13.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.44 (Total Current Assets 152.6m / Total Current Liabilities 44.4m)
Debt / Equity = 0.04 (Debt 5.93m / totalStockholderEquity, last quarter 135.7m)
Debt / EBITDA = 7.63 (negative EBITDA) (Net Debt -55.5m / EBITDA -7.28m)
Debt / FCF = -2.44 (Net Debt -55.5m / FCF TTM 22.8m)
Total Stockholder Equity = 132.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.58% (Net Income -15.6m / Total Assets 186.8m)
RoE = -11.75% (Net Income TTM -15.6m / Total Stockholder Equity 132.6m)
RoCE = -9.76% (EBIT -13.5m / Capital Employed (Equity 132.6m + L.T.Debt 5.93m))
RoIC = -8.06% (negative operating profit) (NOPAT -10.7m / Invested Capital 132.6m)
WACC = 10.43% (E(134.9m)/V(140.8m) * Re(10.57%) + D(5.93m)/V(140.8m) * Rd(9.09%) * (1-Tc(0.21)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.16%
[DCF Debug] Terminal Value 60.14% ; FCFF base≈16.4m ; Y1≈10.7m ; Y5≈4.90m
Fair Price DCF = 1.53 (EV 67.9m - Net Debt -55.5m = Equity 123.4m / Shares 80.8m; r=10.43% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 8.41 | EPS CAGR: 198.8% | SUE: -0.28 | # QB: 0
Revenue Correlation: -77.48 | Revenue CAGR: -3.68% | SUE: -0.42 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=0.18 | Chg30d=-0.061 | Revisions Net=+0 | Growth EPS=+40.0% | Growth Revenue=+0.5%